drugset / Trial / NCT02342067
Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination
RandomizedParallel-groupOpen-labelTreatment
Summary
A single center, open-label, fixed sequence study to evaluate the pharmacokinetics (PK) of Cenicriviroc (CVC) administered with and without Pioglitazone (PGZ), and to evaluate the PK of PGZ administered with and without CVC.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-03
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cenicriviroc | Small molecule | 150 mg | — |
| Subject | Pioglitazone | Small molecule | 45 mg | — |
Indications
No indication recorded.